Medical and Pharmaceutical Eli Lilly inks USD$2.75B AI drug deal with Insilico Medicine Insilico has developed at least 28 drug candidates using generative AI tools Joseph MortonMarch 31, 2026
AI and Autonomy Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI The companies plan to build proof-of-concept models that predict how patients will respond to treatment Joseph MortonMarch 27, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
AI and Autonomy The promises and perils of artificial intelligence: a Mugglehead roundup AI represents a dual-edged force with the capability of reordering society for good or for ill Joseph MortonOctober 31, 2025
AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025